Abstract
ABSTRACTBACKGROUNDPlatelet transfusions are increasing with advances in medical care. Based on FDA criteria, platelet units are assessed byin vitromeasures; however, it is not known how platelet processing and storage duration affect functionin vivo. To address this, we developed a novel platelet transfusion model that meets FDA criteria adapted to mice, and transfused fresh and stored platelets are detected in clotsin vivo.STUDY DESIGN AND METHODSPlatelet units stored in mouse plasma were prepared using a modified platelet rich plasma collection protocol. Characteristics of fresh and stored units, including pH, cell count, in vitro measures of activity, including activation and aggregation, and post-transfusion recovery (PTR), were determined. Lastly, a tail transection assay was conducted using mice transfused with fresh or stored units, and transfused platelets were identified by confocal imaging.RESULTSPlatelet units had acceptable platelet and white cell counts and were negative for bacterial contamination. Fresh and 1-day stored units had acceptable pH; the platelets were activatable by thrombin and ADP, aggregable with thrombin, had acceptable PTR, and were presentin vivoin clots of recipients after tail transection. In contrast, 2-day stored units had clinically unacceptable quality.DISCUSSIONWe developed mouse platelets for transfusion analogous to human platelet units using a modified platelet rich plasma collection protocol with maximum storage of 1 day for an “old” unit. This provides a powerful tool to test how process modifications and storage conditions affect transfused platelet functionin vivo.
Publisher
Cold Spring Harbor Laboratory
Reference29 articles.
1. Has the trend of declining blood transfusions in the United States ended? Findings of the 2019 National Blood Collection and Utilization Survey;Transfusion,2021
2. Free, R.J. , et al., Continued stabilization of blood collections and transfusions in the United States: Findings from the 2021 National Blood Collection and Utilization Survey. Transfusion, 2023.
3. Bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion. Food and Drug Administration, Editor., 2020. CBER Office of Communication, Outreach, and Development: Silver Spring, MD.
4. Gammon, R.R. , et al., Standards Blood Banks and Transfusion Services. 33rd Edition ed. 2022, Bethesda, MD: Association for the Advancement of Blood and Biotherapies (AABB).
5. Metabolites in stored platelets associated with platelet recoveries and survivals;Transfusion,2016